Biotechnology
LYRA
7.95
price down icon2.33%   -0.19
after-market Handel nachbörslich: 7.95

Lyra Therapeutics Inc (LYRA)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$8.14
Offen:
$8.2
24-Stunden-Volumen:
13,794
Relative Volume:
0.02
Marktkapitalisierung:
$10.54M
Einnahmen:
$1.47M
Nettoeinkommen (Verlust:
$-97.61M
KGV:
-5.3356
EPS:
-1.49
Netto-Cashflow:
$-80.90M
1W Leistung:
+0.63%
1M Leistung:
-35.37%
6M Leistung:
-15.25%
1J Leistung:
-48.54%
1-Tages-Spanne:
Value
$7.9401
$8.33
1-Wochen-Bereich:
Value
$7.7699
$8.6699
52-Wochen-Spanne:
Value
$3.8101
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
Firmenname
Lyra Therapeutics Inc
Name
Sektor
Healthcare (1164)
Name
Branche
Biotechnology (651)
Name
Telefon
617-373-4600
Name
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Name
Mitarbeiter
30
Name
Twitter
@LyraTx
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
LYRA's Discussions on Twitter

Vergleichen Sie LYRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LYRA
Lyra Therapeutics Inc
 7.95 13.01M 1.47M -97.61M -80.90M -1.49
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
 591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 291.47 32.08B 3.81B -644.79M -669.77M -6.24

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-07 Herabstufung BofA Securities Buy → Underperform
2024-05-07 Herabstufung H.C. Wainwright Buy → Neutral
2024-05-07 Herabstufung Jefferies Buy → Hold
2024-05-06 Herabstufung William Blair Outperform → Mkt Perform
2023-10-06 Fortgesetzt BTIG Research Buy
2023-08-31 Eingeleitet H.C. Wainwright Buy
2022-05-24 Eingeleitet Cantor Fitzgerald Overweight
2020-05-26 Eingeleitet BTIG Research Buy
2020-05-26 Eingeleitet BofA/Merrill Buy
2020-05-26 Eingeleitet Jefferies Buy
2020-05-26 Eingeleitet William Blair Outperform
Alle ansehen

Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten

pulisher
Jul 25, 2025

How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What makes Lyra Therapeutics Inc. stock price move sharplyHigh Return Potential - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus

Jul 22, 2025
pulisher
Jul 16, 2025

How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru

Jul 16, 2025
pulisher
Jul 14, 2025

Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com

Jul 14, 2025
pulisher
Jul 13, 2025

Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World

Jul 13, 2025
pulisher
Jul 05, 2025

Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 05, 2025
pulisher
Jun 27, 2025

Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times

Jun 27, 2025
pulisher
Jun 26, 2025

Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 23, 2025

Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com

Jun 23, 2025
pulisher
Jun 16, 2025

Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha

Jun 16, 2025
pulisher
Jun 14, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise

Jun 12, 2025

Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie LYRA

biotechnology GMAB
$23.40
price down icon 0.97%
biotechnology RPRX
$36.67
price up icon 0.22%
biotechnology INSM
$103.95
price up icon 0.42%
biotechnology SMMT
$28.67
price up icon 3.99%
biotechnology BNTX
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):